Related references
Note: Only part of the references are listed.Use of monoamine oxidase inhibitors in chronic neurodegeneration
Peter Riederer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis
Carlo Cattaneo et al.
JOURNAL OF PARKINSONS DISEASE (2017)
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients
P. Barone et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Overview of Glutamatergic Dysregulation in Central Pathologies
Tanya Miladinovic et al.
BIOMOLECULES (2015)
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
Two-Year, Randomized, Controlled Study of Safinamide as Add-on to Levodopa in Mid to Late Parkinson's Disease
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
Non-dopaminergic Treatments for Motor Control in Parkinson's Disease
Susan H. Fox
DRUGS (2013)
Mood disorders in Parkinson's disease
Louis C.S. Tan
PARKINSONISM & RELATED DISORDERS (2011)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
The Effect of Pramipexole on Mood and Motivational Symptoms in Parkinson's Disease: A Meta-analysis of Placebo-Controlled Studies
Albert F. G. Leentjens et al.
CLINICAL THERAPEUTICS (2009)
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Rodrigo Machado-Vieira et al.
NEUROSCIENTIST (2009)
Safinamide - From molecular targets to a new anti-Parkinson drug
C. Caccia et al.
NEUROLOGY (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Beyond monoamines: Glutamatergic function in mood disorders
A Kugaya et al.
CNS SPECTRUMS (2005)